Carol Ann Mase

Title: The Innovations of Carol Ann Mase

Introduction

Carol Ann Mase is an accomplished inventor based in Ringoes, NJ (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that interact with progesterone receptors. Her work has implications for various therapeutic applications.

Latest Patents

Carol Ann Mase holds a patent for "Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents." This invention relates to 2-arylimino heterocycles, including 2-arylimino-1,3-thiazolidines, 2-arylimino-2,3,4,5-tetrahydro-1,3-thiazines, 2-arylimino-1,3-thiazolidin-4-ones, 2-arylimino-1,3-thiazolidin-5-ones, and 2-arylimino-1,3-oxazolidines. These compounds are utilized in modulating progesterone receptor-mediated processes and are essential for developing pharmaceutical compositions for therapeutic use. She has 1 patent to her name.

Career Highlights

Carol Ann Mase is currently employed at Bayer Corporation, where she continues to innovate and contribute to the field of pharmaceutical research. Her expertise in chemistry and pharmacology has positioned her as a valuable asset in her organization.

Collaborations

Throughout her career, Carol has collaborated with notable colleagues, including Brian R. Dixon and Cedo Martin Bagi. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic agents.

Conclusion

Carol Ann Mase exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions to the development of progesterone receptor binding agents highlight her commitment to advancing medical science. Her work continues to inspire future generations of inventors and researchers.